A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 701–800 of 1,002
Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids
Way, G. W., Jackson, K. G., Muscu, S., & Zhou, H. (2022) · Cells · doi:10.3390/cells11081374 · Cited by 39
“This inhibition results from a reduction in AMP-activated protein kinase (AMPK) activity, increasing acetyl-CoA carboxylase activity and increasing malonyl-CoA levels [45].”
BackgroundMarchianò, S., Biagioli, M., Roselli, R., Zampella, A., Giorgio, C. D., Bordoni, M., Bellini, R., Urbani, G., Morretta, E., Monti, M. C., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159218 · Cited by 36
Transhepatic bile acid kinetics in pigs and humans
Eggink, H. M., van Nierop, F. S., Schooneman, M. G., Boelen, A., Kalsbeek, A., Koehorst, M., Have, G. A. M. T., de Brauw, L. M., Groen, A. K., Romijn, J. A., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.015 · Cited by 40
FXR‐deficiency confers increased susceptibility to torpor
Cariou, B., Bouchaert, E., Abdelkarim, M., Dumont, J., Caron, S., Fruchart, J.-C., Burcelin, R., Kuipers, F., & Staels, B. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.064 · Cited by 35
“decreased proportion of deoxycholate which is the highest affinity BA ligand for the receptor TGR5 (Gpbar1) (Fig. 1B) [ 9 ].”
BackgroundKühlkamp, T., Keitel, V., Helmer, A., Häussinger, D., & Kubitz, R. (2005) · Biological Chemistry · doi:10.1515/bc.2005.122 · Cited by 35
Mechanistic insights into the liver–brain axis during chronic liver disease
Siddle, M. R., Durán, R. G., Goel, D., Renquist, B. J., Holt, M. K., & Hadjihambi, A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01142-z · Cited by 41
“This process is mediated by the activation of Takeda G protein-coupled receptor 5 (TGR5), a G protein-coupled receptor responsive to bile acids, which, in turn, inhibits the expression of agouti-related peptide/neuropeptide Y in the arcuate nucleus 200,201 .”
Secondary Unconjugated Bile Acids Induce Hepatic Stellate Cell Activation
Saga, K., Iwashita, Y., Hidano, S., Aso, Y., Isaka, K., Kido, Y., Tada, K., Takayama, H., Masuda, T., Hirashita, T., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103043 · Cited by 38
“Regarding the degree of involvement of BAs in organs, excluding the liver, G protein-coupled receptor (TGR5) was reported as membrane-type BA receptor that is activated by BAs in the order of LCA > DCA > CDCA > CA in intestinal neuroendocrine cells, as well as the gall bladder, spleen, brown adipose tissue, macrophage…”
BackgroundBile acid treatment and FXR agonism lower postprandial lipemia in mice
Farr, S., Stankovic, B., HOFFMAN, S. S., Masoudpoor, H., Baker, C., Taher, J., Dean, A. E., Anakk, S., & Adeli, K. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00386.2018 · Cited by 38
The Bile Acid Receptor TGR5 and Liver Regeneration
Bidault, V., Pean, N., Doignon, I., Humbert, L., Rainteau, D. P., & Tordjmann, T. (2015) · Digestive Diseases · doi:10.1159/000371668 · Cited by 35
Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block
Yanovsky, Y., Schubring, S. R., Yao, Q., Zhao, Y., Li, S., May, A., Haas, H. L., Lin, J.-S., & Sergeeva, O. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042512 · Cited by 34
“UDCA [35]), BS transporters and intracellular signal cascades”
BackgroundIguchi, Y., Yamaguchi, M., Sato, H., Kihira, K., Nishimaki‐Mogami, T., & Une, M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m004051 · Cited by 37
“[10] OH OH”
BackgroundLi, B., Yang, N., Li, C., Li, C., Gao, K., Xie, X., Dong, X., Yang, J., Yang, Q., Tong, Z., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.120 · Cited by 34
Bile reflux and bile acids in the progression of gastric intestinal metaplasia
Qu, X., & Shi, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002290 · Cited by 37
“1664 vitamin D3 receptor, and G protein-coupled bile acid receptor (TGR5).([19-24]) Recently, growing evidence has shown that bile reflux, as one of the risk factors for GC, is related to GIM.”
BackgroundBile acids and microbes in metabolic disease
Sah, D. K., Arjunan, A., Park, S. Y., & Jung, Y. D. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6846 · Cited by 36
Metagenomic assessment of gut microbial communities and risk of severe COVID-19
Nguyen, L. H., Okin, D. A., Drew, D. A., Battista, V. M., Jesudasen, S. J., Kuntz, T. M., Bhosle, A., Thompson, K. N., Reinicke, T., Lo, C., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01202-6 · Cited by 40
Cole, A. J., Teigen, L. M., Jahansouz, C., Earthman, C. P., & Sibley, S. D. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0171-x · Cited by 35
Marín, J. J. G., Macías, R. I. R., Briz, Ó., Perez, M. J., Blazquez, A. G., Arrese, M. A., & Serrano, M. A. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01680.x · Cited by 37
“Thus, BAs are able to activate the mitogen-activated protein kinases (MAPK) pathway (111, 112) and they are ligands of the membrane-bound receptor associated with G protein TGR5 (113, 114) and of nuclear receptors, such as farnesoid X receptor a (FXRa; NR1H4) (115–117).”
BackgroundAntagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives
Schepetkin, I. A., Khlebnikov, А. I., Kirpotina, L. N., & Quinn, M. T. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.08.036 · Cited by 34
Postgenomic characterization of G-protein-coupled receptors
Mertens, I., Vandingenen, A., Meeusen, T., LOOF, A. D., & Schoofs, L. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.6.657 · Cited by 43
Bile Metabolism and Lithogenesis
O’Connell, K. M., & Brasel, K. J. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.01.004 · Cited by 36
Schepetkin, I. A., Kirpotina, L. N., Khlebnikov, А. I., Jutila, M. A., & Quinn, M. T. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068288 · Cited by 35
“For example, bile acids are antagonists of FPR1/FPR2 (Chen et al., 2000) and agonists for TGR5, a GPCR involved in regulating thyroid hormone signaling and energy homeostasis (Kawamata et al., 2003).”
BackgroundLi, Y., Cheng, K., Niu, C., Lo, S., Cheng, J., & Niu, H. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s131892 · Cited by 38
“(cAMP) to activate protein kinase A, which can induce the transduction of downstream signaling.(1,4) Therefore, TGR5 is known to regulate the lipid and glucose metabolism, energy homeostasis, and inflammation.”
Lee, S., Lee, Y., Choi, E., Cho, Y., & Kim, J. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0741 · Cited by 35
Lin, Q.-H., Tan, X., Wang, W., Zeng, W., Gui, L., Su, M., Liu, C., Jia, W. P., Xu, L., & Lan, K. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.090464 · Cited by 36
“…gut microbiota (Theriot et al., 2014; Buffie et al., 2015), balanced lipid and carbohydrate metabolism (de Aguiar Vallim et al., 2013; Wahlstrom et al., 2016), insulin sensitivity (Maruyama et al., 2002; Kawamata et al., 2003), and innate immunity (Inagaki et al., 2006; Vavassori et al., 2009).”
BackgroundGut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Wang, J., Zhu, N., Su, L., & Yang, R. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216582 · Cited by 37
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach
Mousa, H. S., Carbone, M., Malinverno, F., Ronca, V., Gershwin, M. E., & Invernizzi, P. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.003 · Cited by 36
Bile acids as global regulators of hepatic nutrient metabolism
Hylemon, P. B., Takabe, K., Dozmorov, M. G., Nagahashi, M., & Zhou, H. (2017) · Liver Research · doi:10.1016/j.livres.2017.03.002 · Cited by 38
“acid (CDCA) > cholic acid (CA) > ursodeoxycholic acid (UDCA) [7,8].”
Chen, X., Liu, Y., Guo, Z., Chen, Y., Li, M., Huang, C., Chen, Z., & Meng, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5232 · Cited by 45
“Another effect of TGR5 activation is the stimulation of glucagon-like peptide 1 (GLP1) secretion (24,32-34).”
de Haan, L. R., van der Lely, S. J., Warps, A. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Dias, L. M., Bruinsma, B. G., Uygun, K., et al. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.001 · Cited by 35
“Compared to adipocytes, myocytes, and macrophages that are usually exposed to low levels of bile acids in the systemic circulation, cholangiocytes are routinely exposed to high levels of bile acids, and bile acid signaling through TGR5 in cholangiocytes may be more pathophysiologically relevant.”
BackgroundInfluentialThe cardiovascular protective effect and mechanism of calycosin and its derivatives
Li, P., Zhang, X.-F., Wei, W., Zhang, J., & Li, Z. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)60034-6 · Cited by 33
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
Yu, D. D., Sousa, K. M., Mattern, D. L., Wagner, J. E., Fu, X., Vaidehi, N., FORMAN, B. M., & Huang, W. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.048 · Cited by 35
Zhu, J., Ye, Y., Ning, M., Mándi, A., Feng, Y., Zou, Q., Kurtán, T., Leng, Y., & Shen, J. (2013) · ChemMedChem · doi:10.1002/cmdc.201300144 · Cited by 33
Zambad, S. P., Tuli, D., Matur, A., Ghalsasi, S., Chaudhary, A., Deshpande, S., Gupta, R., Chauthaiwale, V. M., & Dutt, C. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s50209 · Cited by 34
“TGR5 has been identified as a lithocholic acid-activated receptor.(12,16) The natural bile acid ligands of the TGR5 receptor, ie, lithocholic acid and taurocholic acid, have been shown to affect energy homeostasis via TGR5-mediated effects on energy expenditure and glucose disposal.”
BackgroundScotti, E., Gilardi, F., Godio, C., Gers, E., Krneta, J., Mitro, N., Fabiani, E. D., Caruso, D., & Crestani, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7280-y · Cited by 35
Hendrick, S. M., Mroz, M. S., Greene, C. M., Keely, S. J., & Harvey, B. J. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2013 · Cited by 35
Prolonged QT Interval in Cirrhosis: Twisting Time?
Lee, W., Vandenberk, B., Raj, S. R., & Lee, S. S. (2022) · Gut and Liver · doi:10.5009/gnl210537 · Cited by 36
“There is evidence that cardiac myocytes express nuclear bile acid receptors: farnesoid-X receptor(59) and Takeda G-protein receptor 5.(60,61) The underlying cellular pathophysiology was studied by Ward et al.”
BackgroundLinking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
Ren, Z., Li, C.-X., Ma, C., Chen, D., Chen, J., Xu, W., Chen, C.-A., Cheng, F., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113045 · Cited by 34
Taste receptors in the gut – A new target for health promoting properties in diet
Ekstrand, B., Young, J. F., & Rasmussen, M. K. (2017) · Food Research International · doi:10.1016/j.foodres.2017.08.024 · Cited by 33
“…in the cholangiocytes as well as in a variety of other cell types, such as brown adipose tissue, brain, gall bladder epithelium, intestines, spleen, endothelial cells, Kupffer cells and CD14+ cells (Kawamata et al., 2003; Keitel, Donner, Winandy, Kubitz, & Haussinger, 2008; Maruyama et al., 2002).”
BackgroundBecker, L. S., Bishop, E. S., Sinha, S. R., Haileselassie, Y., & Habtezion, A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.001 · Cited by 35
Oshiro, T., Nagata, S., Wang, C., Takahashi, T., Tsuji, H., Asahara, T., Nomoto, K., Takei, H., Nittono, H., & Yamashiro, Y. (2019) · Biomedicine Hub · doi:10.1159/000502935 · Cited by 32
Wu, H., Yu, N., Wang, X., Yang, Y., & Liang, H. (2020) · Biological Research · doi:10.1186/s40659-020-00323-1 · Cited by 32
Zhao, S., Li, X., Peng, W., Wang, L., Ye, W., Zhao, Y., Yin, W., Chen, W., Li, W., & Wang, Y. (2021) · RSC Advances · doi:10.1039/d0ra10168k · Cited by 32
Role of bile acids in overweight and obese children and adolescents
Giannini, C., Mastromauro, C., Scapaticci, S., Gentile, C., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011994 · Cited by 32
“Despite the fact that it can be activated by multiple BAs, LCA is the most potent natural agonist (50).”
BackgroundInfluentialLiver-derived metabolites as signaling molecules in fatty liver disease
Keles, U., Ow, J. R., Kuentzel, K. B., Zhao, L. N., & Kaldis, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04658-8 · Cited by 40
“A portion of the bile salts, however, becomes deconjugated by microbial hydrolases, and bacterial enzymes further convert these into secondary bile acids: lithocholic acid (LCA) and U. Keles et al. 1 3 4 Page 6 of 14 deoxycholic acid (DCA), which are derived from CDCA and from CA [99], respectively.”
BackgroundInfluentialMichaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 36
Gertzen, C. G. W., Spomer, L., Smits, S. H. J., Häussinger, D., Keitel, V., & Gohlke, H. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.024 · Cited by 34
Regulation of the proprotein convertase subtilisin/kexin type 9 in intestinal epithelial cells
Leblond, F., Seidah, N. G., Précourt, L.-P., Delvin, E., Dominguez, M., & Levy, E. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90424.2008 · Cited by 30
“In fact, BA are ligands for G protein-coupled receptors and modulate several nuclear hormone receptors (27, 35, 36).”
BackgroundSuga, T., Yamaguchi, H., Ogura, J., & Mano, N. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.03.003 · Cited by 33
Li, J., Cheng, R., & Wan, H. (2020) · Bioscience Reports · doi:10.1042/bsr20193482 · Cited by 35
Insulin resistance, adipose depots and gut: Interactions and pathological implications
Gastaldelli, A., Natali, A., Vettor, R., & Corradini, S. G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.013 · Cited by 42
“BAs that activate mitogen-activated protein kinase pathways [34,35] are ligands for the G-protein-coupled receptor (GPCR) TGR5 [36,37] and activate nuclear hormone receptors such as farnesoid X receptor (FXR- ) [38–40].”
BackgroundBile acids and glucocorticoid metabolism in health and disease
Theiler-Schwetz, V., Zaufel, A., Schlager, H., Obermayer-Pietsch, B., Fickert, P., & Zollner, G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.001 · Cited by 31
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
Zhu, J., Lyu, J., Zhao, R., Liu, G., & Wang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1272479 · Cited by 37
“Research has shown that BAs in combination with its activating transcription factor, farnesoid X receptor (FXR), inhibit cholesterol transport and increase cholesterol excretion by macrophages in order to reduce cholesterol concentration in plasma, and can be used as a therapeutic target for dyslipidemia (Figure 2; Ka…”
BackgroundEvidence and Mechanism of Bile Acid–Mediated Gut-Brain Axis in Anxiety and Depression
Idahosa, S. O., Diarra, R., Ranu, H. K., Nasiri, R. H., & Higuchi, S. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.10.019 · Cited by 33
Mousa, R. S., Invernizzi, P., & Mousa, H. S. (2024) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2024.1452430 · Cited by 32
Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice
Eggink, H. M., Tambyrajah, L. L., van den Berg, R., Mol, I. M., van den Heuvel, J. K., Koehorst, M., Groen, A. K., Boelen, A., Kalsbeek, A., Romijn, J. A., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0503 · Cited by 33
Druggable Lipid GPCRs: Past, Present, and Prospects
Mizuno, H., & Kihara, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50621-6_10 · Cited by 34
TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present)
Bhimanwar, R. S., & Mittal, A. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.1994551 · Cited by 31
“The increase in insulin secretion reduces the liver’s production of glucose [15].”
BackgroundBile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication
Joyce, S. A., & O'Malley, D. (2022) · The Journal of Physiology · doi:10.1113/jp281727 · Cited by 36
“LCA is the most potent natural agonist of TGR5 (Kawamata et al., 2003), and has been shown to influence glucose metabolism, neuronal function, immune system control and liver regeneration (Guo et al.”
Background4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists
Zou, Q., Duan, H., Ning, M., Liu, J., Feng, Y., Zhang, L., Zhu, J., Leng, Y., & Shen, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.031 · Cited by 31
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists
Tognolini, M., Incerti, M., Pala, D., Russo, S., Castelli, R., Hassan‐Mohamed, I., Giorgio, C., & Lodola, A. (2013) · ChemMedChem · doi:10.1002/cmdc.201300305 · Cited by 31
Ursodeoxycholic acid and chemoprevention of colorectal cancer
Serfaty, L., Bissonnette, M., & Poupon, R. Y. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.05.005 · Cited by 32
Song, Y., Zhao, M., Zhang, H., Zhang, X., Zhao, J., Xu, J., & Gao, L. (2015) · Endocrine Practice · doi:10.4158/ep15844.or · Cited by 36
Kundu, S., Bansal, S., Muthukumarasamy, K. M., Sachidanandan, C., Motiani, R. K., & Bajaj, A. (2017) · MedChemComm · doi:10.1039/c7md00475c · Cited by 33
Roles of the inflammasome in the gut‑liver axis (Review)
Wang, J., Dong, R., & Zheng, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9679 · Cited by 43
“potency) (79), whereas, LCA is the most potent in activating TGR5 (LCA > DCA > CDCA > CA) (83).”
BackgroundBrandvold, K. R., Weaver, J., Whidbey, C., & Wright, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-37656-7 · Cited by 31
Impact of the gut microbiome on atherosclerosis
Mao, Y., Kong, C., Zang, T., You, L., Wang, L., Shen, L. W., & Ge, J. (2024) · mLife · doi:10.1002/mlf2.12110 · Cited by 35
“FXR is mainly expressed in the liver and intestines and is involved in the regulation of lipid metabolism, especially the transport, synthesis, and use of triacylglycerol 58 .”
BackgroundLeva, F. S. D., Festa, C., Renga, B., Sepe, V., Novellino, E., Fiorucci, S., Zampella, A., & Limongelli, V. (2015) · Scientific Reports · doi:10.1038/srep16605 · Cited by 32
Lai, W., Cao, A., Li, J., Zhang, W., & Zhang, L. (2018) · The Journal of Applied Poultry Research · doi:10.3382/japr/pfy040 · Cited by 30
Paraiso, I. L., Revel, J. S., Choi, J., Miranda, C. L., Lak, P., Kioussi, C., Bobe, G., Gombart, A. F., Raber, J., Maier, C. S., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000341 · Cited by 36
Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
Long, X.-Q., Liu, M., Liu, Z.-H., Xia, L.-Z., Lu, S.-P., Xu, X.-P., & Wu, M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i27.4252 · Cited by 30
Zhang, T., Liu, W., Lu, H., Cheng, T., Wang, L., Wang, G., Zhang, H., & Chen, W. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2278155 · Cited by 33
“Compared to healthy individuals, patients with constipation tend to show low gene and protein expression of TGR5 and FXR in the colon tissue (Fan et al. 2022), and loss of TGR5 function leads to fewer and drier fecal pellets (Alemi et al. 2013).”
InfluentialZheng, C., Zhou, W., Wang, T., You, P., Zhao, Y., Yang, Y., Wang, X., Luo, J., Chen, Y., Liu, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134051 · Cited by 35
“TGR5, a membrane receptor for bile acids (BAs) [22], is highly expressed in intestine, brown adipose tissue and liver [23, 24].”
BackgroundJia, L., Jiang, D., Hu, P., Li, X., Shi, H., Cheng, D., & Zhang, L. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.03.016 · Cited by 32
Bile Acid Sequestrants: Glucose-Lowering Mechanisms
Prawitt, J., & Staels, B. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0096 · Cited by 32
“33,34 Mainly expressed in gallbladder, ileum, colon, brown and white adipose tissue, and, to a lesser extent, in skeletal muscle and liver, TGR5 is activated by nanomolar concentrations of LCA and taurine-conjugated lithocholic acid (TLCA) and micromolar concentrations of CA, DCA, and CDCA.”
Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats
Lo, S., Li, Y., Cheng, K., Niu, C., Cheng, J., & Niu, H. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1409-9 · Cited by 31
Rao, J., Yang, C., Lu, H., Lu, H., Yang, S., Zhuang, L., Cheng, X., Zhang, F., Cheng, F., & Wang, X. (2018) · International Immunology · doi:10.1093/intimm/dxaa002 · Cited by 30
Biliary Transport Systems: Short‐Term Regulation
Kubitz, R., Helmer, A., & Häussinger, D. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00030-3 · Cited by 33
Lei, S., Huang, F., Zhao, A., Chen, T., Chen, W., Xie, G., Zheng, X., Zhang, Y., Yu, H., Zhang, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700055r · Cited by 30
“Multiple BAs that activate TGR5 include conjugated and unconjugated forms of DCA (37).”
BackgroundThe bile–gut axis and metabolic consequences of cholecystectomy
Lange, A. H., Pedersen, M. G., Ellegaard, A., Nerild, H. H., Brønden, A., Sonne, D. P., & Knop, F. K. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae034 · Cited by 30
Bile acids and their receptors in hepatic immunity
Fiorucci, S., Marchianò, S., Distrutti, E., & Biagioli, M. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.005 · Cited by 31
“2,5,43 GPBAR1 plays a crucial role in dampening in fl ammatory responses, 44 particularly through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-k B) signaling and the suppression of in fl ammasome assembly.”
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 32
Synthetic FXR Agonist GW4064 Is a Modulator of Multiple G Protein–Coupled Receptors
Singh, N., Yadav, M., Singh, A. K., Kumar, H., Dwivedi, S. K. D., Mishra, J. S., Gurjar, A. A., Manhas, A., Chandra, S., Yadav, P. N., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1353 · Cited by 33
Hepatoprotective impact of the bile acid receptor TGR5
Merlen, G., Bidault, V., Kahale, N., Glénisson, M., Bedoya, J. U., Doignon, I., Garcin, I., Humbert, L., Rainteau, D. P., & Tordjmann, T. (2020) · Liver International · doi:10.1111/liv.14427 · Cited by 30
Zhang, J., Hu, C., Li, X., Liang, L., Zhang, M., Chen, B., Liu, X., & Yang, D. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500324 · Cited by 31
Chen, Z., Feng, J., Hu, S., Ye, H., Ma, S., Fu, W., Yang, Q., & Zhang, X. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07308-4 · Cited by 30
“Studies have confirmed that TGR5 is mainly activated by hydrophobic secondary bile acids LCA and DCA, and CDCA and CA are also activators of TGR5 [35, 36].”
BackgroundBile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease
Chen, W., Wang, D., Deng, X., Zhang, H., Dong, D., Su, T., Lu, Q., Jiang, C., Ni, Q., Cui, Y., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323231 · Cited by 31
“38,39 Additionally, certain BA metabolites, such as LCA, 3-oxoLCA, and isoalloLCA, can directly regulate the balance between T helper 17 and regulatory T cells, thereby influencing the host’s immune response.”
BackgroundBile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells
Kowal, J. M., Haanes, K. A., Christensen, N. M., & Novak, I. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0107-9 · Cited by 32
“The role of bile acids as signalling molecules and as targets for drug development gained interest during the last years, and several bile acid receptors were discovered, including the nuclear farnesoid receptor (FXR) and the membrane receptor TGR5 (GPBAR1) [1 – 4].”
BackgroundIwata, R., Stieger, B., Mertens, J. C., Müller, T., Baur, K., Frei, P., Braun, J. M., Vergopoulos, A., Martin, I. V., Schmitt, J., et al. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01363.x · Cited by 29
Regulation of nutrition-associated receptors in blood monocytes of normal weight and obese humans
Pivovarova‐Ramich, O., Hornemann, S., Weimer, S., Lu, Y., Murahovschi, V., Zhuk, S., Seltmann, A., Malashicheva, A., Kostareva, A. A., Kruse, M., et al. (2015) · Peptides · doi:10.1016/j.peptides.2014.11.009 · Cited by 30
Govindan, J. A., Jayamani, E., Zhang, X. L., Breen, P. C., Larkins‐Ford, J., Mylonakis, E. E., & Ruvkun, G. (2015) · Nature Cell Biology · doi:10.1038/ncb3229 · Cited by 29
The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery
Fouladi, F., Mitchell, J. E., Wonderlich, J. A., & Steffen, K. J. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2272-3 · Cited by 29
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
Cheng, J., Cheng, K., Li, Y., Lo, S., Chang, C.-H., & Lee, K. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s113197 · Cited by 30
“Essentially, BA induces TGR5 receptor internalization, activation of extracellular signal-regulated kinase, and intracellular cyclic adenosine monophosphate (cAMP) production in cells.(1,2) In animal models, treatment with TGR5 agonist(s) produces glucagon-like peptide (GLP-1) secretion, which in turn induces insulin…”
BackgroundGreife, A., Felekyan, S., Ma, Q., Gertzen, C. G. W., Spomer, L., Dimura, M., Peulen, T.-O., Wöhler, C., Häussinger, D., Gohlke, H., et al. (2016) · Scientific Reports · doi:10.1038/srep36792 · Cited by 30
“kFRET (1) , kFRET (2) are the FRET rate constants and FRET species fractions, xFRET (1) , xFRET (2) .”
BackgroundMethodInfluentialJi, C., Xie, X., Yin, J., Qi, W., Chen, L., Bai, Y., Wang, N., Zhao, D., Jiang, X., & Jiang, H. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.001 · Cited by 29
Zhang, J., Gao, L.-Z., Chen, Y.-J., Zhu, P.-P., Yin, S.-S., Su, M., Ni, Y., Miao, J., Wu, W.-L., Chen, H., et al. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085670 · Cited by 32
“…gut microbiota (Theriot et al., 2014; Buffie et al., 2015), balanced lipid and carbohydrate metabolism (de Aguiar Vallim et al., 2013; Wahlström et al., 2016), insulin sensitivity (Maruyama et al., 2002; Kawamata et al., 2003), and innate immunity (Inagaki et al., 2006; Vavassori et al., 2009).”
BackgroundBile acid signaling in renal water regulation
Li, S., Li, C., & Wang, W. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00563.2018 · Cited by 30
“The binding of BAs (or synthetic agonists) to TGR5 causes receptor internalization and activation of the intracellular adenylyl cyclase, which, in turn, induces cAMP production and PKA activation, leading to increased phosphorylation of target proteins (17).”
BackgroundBiagioli, M., Marchianò, S., di Giorgio, C., Roselli, R., Bordoni, M., Bellini, R., Fiorillo, B., Sepe, V., Catalanotti, B., Cassiano, C., et al. (2023) · Hepatology · doi:10.1002/hep.32787 · Cited by 28
“GPBAR1 is a cell membrane receptor for secondary bile acids[32] that, in contrast to farnesoid X receptor (FXR), the main bile acid sensor, is not expressed by hepatocytes.”
BackgroundStrain-dependent induction of primary bile acid 7-dehydroxylation by cholic acid
Oton, E. V., Volet, C., Jacquemin, N., Dong, Y., Hapfelmeier, S., Meibom, K. L., & Bernier‐Latmani, R. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03433-y · Cited by 31
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.